These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 33200690)
1. In-silico studies on Myo inositol-1-phosphate synthase of Sinha M; Jagadeesan R; Kumar N; Saha S; Kothandan G; Kumar D J Biomol Struct Dyn; 2022 May; 40(8):3371-3384. PubMed ID: 33200690 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of potential drugs against leishmaniasis targeting catalytic subunit of Bhowmik D; Jagadeesan R; Rai P; Nandi R; Gugan K; Kumar D J Biomol Struct Dyn; 2021 Mar; 39(5):1838-1852. PubMed ID: 32141397 [No Abstract] [Full Text] [Related]
3. Computational evaluation of phytochemicals targeting DNA topoisomerase I in Arya PK; Mandal P; Barik K; Singh DV; Kumar A J Biomol Struct Dyn; 2024 Oct; 42(16):8293-8306. PubMed ID: 37697722 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the inhibitory potential of Valproic acid against histone deacetylase of Prasanna P; Joshi T; Pant M; Pundir H; Chandra S J Biomol Struct Dyn; 2023; 41(12):5447-5464. PubMed ID: 35706132 [TBL] [Abstract][Full Text] [Related]
5. In-silico screening and validation of high-affinity tetra-peptide inhibitor of Leishmania donovani O-acetyl serine sulfhydrylase (OASS). Kant V; Vijayakumar S; Sahoo GC; Ali V; Singh K; Chaudhery SS; Das P J Biomol Struct Dyn; 2019 Feb; 37(2):481-492. PubMed ID: 29415627 [TBL] [Abstract][Full Text] [Related]
6. Screening of Novel Inhibitors Against Leishmania donovani Calcium ion Channel to Fight Leishmaniasis. Kashif M; Manna PP; Akhter Y; Alaidarous M; Rub A Infect Disord Drug Targets; 2017; 17(2):120-129. PubMed ID: 28034363 [TBL] [Abstract][Full Text] [Related]
7. MCK1 is a novel regulator of myo-inositol phosphate synthase (MIPS) that is required for inhibition of inositol synthesis by the mood stabilizer valproate. Yu W; Daniel J; Mehta D; Maddipati KR; Greenberg ML PLoS One; 2017; 12(8):e0182534. PubMed ID: 28817575 [TBL] [Abstract][Full Text] [Related]
8. Phosphonate and α-fluorophosphonate analogs of d-glucose 6-phosphate as active-site probes of 1l-myo-inositol 1-phosphate synthase. Ramos-Figueroa JS; Vetter ND; Palmer DRJ Methods Enzymol; 2023; 685():57-93. PubMed ID: 37245915 [TBL] [Abstract][Full Text] [Related]
10. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach. Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998 [TBL] [Abstract][Full Text] [Related]
11. Structure-based drug designing against Sarma M; Borkotoky S; Dubey VK J Biomol Struct Dyn; 2024 Sep; 42(14):7628-7636. PubMed ID: 37491862 [TBL] [Abstract][Full Text] [Related]
12. Comparative modeling and virtual screening for the identification of novel inhibitors for myo-inositol-1-phosphate synthase. Azam SS; Sarfaraz S; Abro A Mol Biol Rep; 2014 Aug; 41(8):5039-52. PubMed ID: 24752405 [TBL] [Abstract][Full Text] [Related]
13. A leishmaniasis study: structure-based screening and molecular dynamics mechanistic analysis for discovering potent inhibitors of spermidine synthase. Grover A; Katiyar SP; Singh SK; Dubey VK; Sundar D Biochim Biophys Acta; 2012 Dec; 1824(12):1476-83. PubMed ID: 22684087 [TBL] [Abstract][Full Text] [Related]
14. Homology modelling, molecular docking, and molecular dynamics simulations reveal the inhibition of Leishmania donovani dihydrofolate reductase-thymidylate synthase enzyme by Withaferin-A. Vadloori B; Sharath AK; Prabhu NP; Maurya R BMC Res Notes; 2018 Apr; 11(1):246. PubMed ID: 29661206 [TBL] [Abstract][Full Text] [Related]
15. Validation of NAD synthase inhibitors for inhibiting the cell viability of Mandal H; Vijayakumar S; Yadav S; Kumar Singh S; Das P J Biomol Struct Dyn; 2019 Oct; 37(17):4481-4493. PubMed ID: 30526395 [TBL] [Abstract][Full Text] [Related]
16. Investigation into in silico and in vitro approaches for inhibitors targeting MCM10 in Leishmania donovani: a comprehensive study. Saha S; Sharma A; Bhowmik D; Kumar D Mol Divers; 2024 May; ():. PubMed ID: 38722455 [TBL] [Abstract][Full Text] [Related]
17. Drug repurposing based novel anti-leishmanial drug screening using Rai P; Arya H; Saha S; Kumar D; Bhatt TK J Biomol Struct Dyn; 2022; 40(21):10812-10820. PubMed ID: 36529188 [TBL] [Abstract][Full Text] [Related]
18. Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches. Nath M; Bhowmik D; Saha S; Nandi R; Kumar D Sci Rep; 2024 Feb; 14(1):3246. PubMed ID: 38332162 [TBL] [Abstract][Full Text] [Related]
19. Substrate specificity of the Leishmania donovani myo-inositol transporter: critical role of inositol C-2, C-3 and C-5 hydroxyl groups. Mongan TP; Ganapasam S; Hobbs SB; Seyfang A Mol Biochem Parasitol; 2004 May; 135(1):133-41. PubMed ID: 15287594 [TBL] [Abstract][Full Text] [Related]
20. Identification of two natural compound inhibitors of Leishmania donovani Spermidine Synthase (SpdS) through molecular docking and dynamic studies. V M V; Dubey VK; Ponnuraj K J Biomol Struct Dyn; 2018 Aug; 36(10):2678-2693. PubMed ID: 28797195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]